After Hours
$
32.42
Change
+0.03 +0.09%
Volume
Volume 35,951
Jun 2, 2023, 5:31 p.m.
Quotes are delayed by 20 min
Previous close
$ 31.39
$ 32.39
Change
+1.00 +3.19%
Day low
Day high
$31.34
$32.59

52 week low
52 week high
$20.67
$62.75

Market cap
$3.73B
Average volume
2.10M
P/E ratio
N/A
Rev. per Employee
$268,909
EPS
-6.50
Dividend
N/A
Div yield
N/A
Ex dividend date
N/A
MarketWatch News on GH
-
Illumina’s FTC Fight Could Reshape U.S. Merger Policy
- Barron's Online
-
Guardant Health stock falls after secondary offering announced
- Wallace Witkowski
-
UBS ups Guardant Health price target to $43 from $40
- Steve Gelsi
-
OPEC Makes the Fed’s Job Harder. That May End Up Hurting Investors.
- Barron's Online
-
U.S. Orders Illumina to Divest Cancer Tester Grail
- Barron's Online
-
Maxar, Guardant Health, Faraday, and More Stock Market Movers Friday
- Barron's Online
-
Illumina's New Gene-Sequencing Products Pressure Challengers
- Barron's Online
-
How Illumina’s Big Bet on Cancer Screener Grail Went Wrong
- Barron's Online
-
Judge Rejects FTC Challenge of Illumina's Acquisition of Grail
- Barron's Online
-
- Barron's Online
-
Illumina Will Be Fine Despite Recent Concerns, Says CEO
- Barron's Online
-
Illumina Stock Plunges Despite Strong Results, Gene-Sequencing Sales
- Barron's Online
- Loading more headlines...
Other News on GH
-
- Edgar Online - (EDG = 10Q, 10K)
-
- Edgar Online - (EDG = 10Q, 10K)
-
Sicart Associates LLC Buys 2, Sells 3 in 4th Quarter
- GuruFocus.com
-
Guardant Health Drops 30% as Cancer Test Disappoints
- GuruFocus.com
-
EU Tells Illumina How to Unwind Deal to Buy Cancer-Test Developer Grail
- The Wall Street Journal Interactive Edition
-
Guardant Health, Inc. (GH) Q3 2022 Earnings Call Transcript
- Seeking Alpha
-
- Edgar Online - (EDG = 10Q, 10K)
-
Cancer-Detecting Blood Tests Gain Ground as New Market Opens Up
- The Wall Street Journal Interactive Edition
Press Releases on GH
-
Guardant Health Releases Inaugural ESG Report
- BusinessWire - BZX
-
Guardant Health Reports First Quarter 2023 Financial Results
- BusinessWire - BZX
-
Guardant Health Announces Additions to Leadership Team
- BusinessWire - BZX
-
Guardant Health Announces ECLIPSE Study Update Call on May 9, 2023
- BusinessWire - BZX
-
Guardant Health to Participate in the BofA Securities 2023 Healthcare Conference
- BusinessWire - BZX
-
Guardant Health to Report First Quarter 2023 Financial Results on May 9, 2023
- BusinessWire - BZX
Rates »
National averages from Bankrate.com
National averages from Bankrate.com
National averages from Bankrate.com